# HD-tDCs to Improve Upper Extremity Function in Patients With Acute Middle Cerebral Artery Stroke

> **NCT04000269** · NA · WITHDRAWN · sponsor: **Milton S. Hershey Medical Center**

## Conditions studied

- Middle Cerebral Artery Stroke

## Interventions

- **DEVICE:** Soterix MxN Neuromodulation device
- **DEVICE:** Sham Stimulation

## Key facts

- **NCT ID:** NCT04000269
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-07-05
- **Primary completion:** 2022-09-05
- **Final completion:** 2022-09-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Did not receive IRB approval
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04000269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04000269, "HD-tDCs to Improve Upper Extremity Function in Patients With Acute Middle Cerebral Artery Stroke". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04000269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*